Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension

Clinical Science

Volumn 103, Issue 2, 2002, Pages 151-155

  Ekholm, Mikael ^a   Wallén, N Håkan ^a   Johnsson, Hans ^a   Eliasson, Keith ^a   Kahan, Thomas ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

Angiotensin converting enzyme inhibitor; Fibrinogen; Mental stress; Thrombin; Thrombin antithrombin complex

Indexed keywords

BLOOD CLOTTING FACTOR 7; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; RAMIPRIL; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME INHIBITION; EXERCISE TEST; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; MENTAL STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBIN TIME; THROMBOEMBOLISM;

EID: 0036343065     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1030151     Document Type: Article

References (24)

1. Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
2. Endothelium-dependent vasodilation in hypertension: A review
3. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health study
4. Hemostasis in normotensive and hypertensive men: Results of the PROCAM Study
5. Haemostatic variables in arterial hypertension
6. Prothrombin fragment 1 + 2 is a risk factor for myocardial infarction in treated hypertensive men
7. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
8. Blood-pressure reduction and cardiovascular risk in HOPE study
9. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease
10. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
11. The theological and hemostatic factors in hypertension
12. Platelet activation during angiotensin II infusion in healthy volunteers
13. The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension
14. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT) test
15. Determination of human thrombin antithrombin III complex in plasma with enzyme-linked immunosorbent assay
16. A simple assay for determination of factor VII in microtiter plates
17. Captopril reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIIa in early postmyocardial infarction stage
18. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients
19. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rythm. Effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy
20. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease
21. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration
22. Atherosclerosis and the coagulation system
23. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
24. Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: Has antihypertensive therapy any influence?